Vous n'êtes pas connecté(e)
15
1
Blue Sky Vaccines GmbH
Société
|
Autriche
Onglets principaux
A propos de votre organisation
BlueSky is developing a novel interferon-inducing viral vector platform for immunotherapy against cancer, infectious diseases and allergy.
We are based in Vienna, Austria, and employ 12 people. To date we were able to raise EU 7m and are financed until mid 2020.
We expect first patients in our clinical trial phase I against HPV induced cancer in summer 2019.
The fundraising process for clinical trials phase II has already begun. We are looking for partners able to invest EUR 25m.
Réseau (0)
Il n'y a pas encore d'organisations dans le réseau.